400 related articles for article (PubMed ID: 9216739)
21. Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?
Traul DL; Sieber F
J Photochem Photobiol B; 2015 Dec; 153():153-63. PubMed ID: 26410039
[TBL] [Abstract][Full Text] [Related]
22. Merocyanine 540-sensitized photoinactivation of leukemia cells: effects of dose fractionation.
Qiu K; Sieber F
Photochem Photobiol; 1992 Oct; 56(4):489-93. PubMed ID: 1454878
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.
Tsujino I; Miyagi K; Sampson RW; Sieber F
Photochem Photobiol; 2006; 82(2):458-65. PubMed ID: 16613499
[TBL] [Abstract][Full Text] [Related]
24. Photodamaging effects of merocyanine 540 on neutrophils and HL-60 cells.
Smith OM; Traul DL; Sieber F
Exp Hematol; 1992 Dec; 20(11):1278-84. PubMed ID: 1337324
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients.
Anderson GS; Miyagi K; Sampson RW; Sieber F
J Photochem Photobiol B; 2002 Nov; 68(2-3):101-8. PubMed ID: 12468204
[TBL] [Abstract][Full Text] [Related]
26. Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
Meagher RC; Rothman SA; Paul P; Koberna P; Willmer C; Baucco PA
Cancer Res; 1989 Jul; 49(13):3637-41. PubMed ID: 2543500
[TBL] [Abstract][Full Text] [Related]
27. Dye-mediated photosensitization of murine neuroblastoma cells.
Sieber F; Sieber-Blum M
Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of merocyanine 540 uptake and photodynamic cell killing by salicylates.
Feix JB; Anderson MS; Kalyanaraman B
Cancer Res; 1994 Jul; 54(13):3474-8. PubMed ID: 8012969
[TBL] [Abstract][Full Text] [Related]
29. [Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells].
Sato Y; Yamazaki T; Yasukawa K; Kaneita Y; Mochimaru J; Hanai M; Irie T; Kura Y; Sawada U; Horie T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2195-200. PubMed ID: 10635304
[TBL] [Abstract][Full Text] [Related]
30. [Purge of malignant cells from bone marrow by hematoporphyrin derivatives and light exposure in vitro].
Xu CX; Lin L; Huang YY; Liu HY; Wang XR; Wang YX; Zhang BL; Li XR; Hou YH
Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):72-5. PubMed ID: 2144939
[TBL] [Abstract][Full Text] [Related]
31. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
Mumcuoglu M; Weiss L; Spivak J; Slavin S
Bone Marrow Transplant; 1989 Mar; 4(2):143-6. PubMed ID: 2650782
[TBL] [Abstract][Full Text] [Related]
32. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
Sieber F; Gaffney DK; Yamazaki T; Qiu K
Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
[No Abstract] [Full Text] [Related]
33. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.
Huang HF; Chen YZ; Wu Y; Chen P
Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611
[TBL] [Abstract][Full Text] [Related]
34. Purging efficacy of ZnPcH₁-based photodynamic therapy on chronic myeloid leukemia bone marrow.
Huang H; Chen Y; Chen W; Wu Y
Int J Lab Hematol; 2011 Oct; 33(5):477-82. PubMed ID: 21457188
[TBL] [Abstract][Full Text] [Related]
35. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
Moriyama Y; Goto T; Nikkuni K; Aoki A; Furukawa T; Narita M; Koyama S; Kishi K; Takahashi M; Shibata A
Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
Atzpodien J; Gulati SC; Clarkson BD
Cancer Res; 1986 Oct; 46(10):4892-5. PubMed ID: 3756850
[TBL] [Abstract][Full Text] [Related]
37. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F
J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981
[TBL] [Abstract][Full Text] [Related]
38. Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells.
Tsujino I; Anderson GS; Sieber F
Photochem Photobiol; 2001 Feb; 73(2):191-8. PubMed ID: 11272734
[TBL] [Abstract][Full Text] [Related]
39. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
Kühl JS; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of doxorubicin in combination with mafosfamide for in vitro elimination of myeloid and lymphoid tumor cells from human bone marrow.
Domenech J; Georget MT; Gihana E; Colombat P; Brémond JL; Chassaigne M; Lamagnère JP; Binet C
Bone Marrow Transplant; 1992 Feb; 9(2):101-6. PubMed ID: 1571708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
